scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1036495410 |
P356 | DOI | 10.1007/S00125-007-0666-4 |
P8608 | Fatcat ID | release_uu3t6p434rgqxih5dnkczgmzsi |
P932 | PMC publication ID | 1914278 |
P698 | PubMed publication ID | 17415544 |
P5875 | ResearchGate publication ID | 6405784 |
P50 | author | John J. P. Kastelein | Q110410211 |
P2093 | author name string | A Kontush | |
B A Hutten | |||
C B Brouwer | |||
E de Groot | |||
E S G Stroes | |||
F Holleman | |||
H Vink | |||
J B L Hoekstra | |||
J Gort | |||
M J Chapman | |||
M Nieuwdorp | |||
P2860 | cites work | Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes | Q22250887 |
Distribution of glycosaminoglycans in the intima of human aortas: changes in atherosclerosis and diabetes mellitus | Q28268390 | ||
Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial | Q28273112 | ||
Permeation of the luminal capillary glycocalyx is determined by hyaluronan | Q30304200 | ||
Inhibitors of the hyaluronidases | Q34517580 | ||
Measurement of arterial wall thickness as a surrogate marker for atherosclerosis | Q35806072 | ||
The endothelial glycocalyx: a potential barrier between health and vascular disease | Q36251700 | ||
Mechanotransduction and the glycocalyx | Q36440487 | ||
Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group | Q36900139 | ||
Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus | Q37239783 | ||
Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions | Q37486465 | ||
Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus | Q40933115 | ||
Is serum hyaluronan a helpful tool in the management of patients with liver diseases? | Q41566309 | ||
Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion | Q44177932 | ||
Increased transvascular low density lipoprotein transport in insulin dependent diabetes: a mechanistic model for development of atherosclerosis | Q44574970 | ||
Enhanced activity of serum and urinary hyaluronidases in streptozotocin-induced diabetic Wistar and GK rats | Q44613074 | ||
L-Ascorbic acid 6-hexadecanoate, a potent hyaluronidase inhibitor. X-ray structure and molecular modeling of enzyme-inhibitor complexes | Q45025030 | ||
Overexpression of hyaluronan in the tunica media promotes the development of atherosclerosis | Q45261400 | ||
Decorin promotes aortic smooth muscle cell calcification and colocalizes to calcified regions in human atherosclerotic lesions | Q46284879 | ||
Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial | Q46468942 | ||
The role of carotid arterial intima-media thickness in predicting clinical coronary events | Q46619804 | ||
Atherogenic region and diet diminish glycocalyx dimension and increase intima-to-media ratios at murine carotid artery bifurcation | Q46697077 | ||
Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. | Q46917089 | ||
Oxidized lipoproteins degrade the endothelial surface layer : implications for platelet-endothelial cell adhesion. | Q52538626 | ||
Glycosaminoglycans in the human aorta in diabetes mellitus: a study of tunica media from areas with and without atherosclerotic plaque | Q72401496 | ||
The endothelial glycocalyx protects against myocardial edema | Q73127923 | ||
Circulating hyaluronan and hyaluronidase are increased in diabetic rats | Q73683385 | ||
A microtiter-based assay for hyaluronidase activity not requiring specialized reagents | Q73702186 | ||
Elevated C-reactive protein associates with early-stage carotid atherosclerosis in young subjects with type 1 diabetes | Q74530211 | ||
Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes | Q82984599 | ||
High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database | Q82985834 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | type-1 diabetes | Q124407 |
atherosclerosis | Q12252367 | ||
P304 | page(s) | 1288-93 | |
P577 | publication date | 2007-06-01 | |
P1433 | published in | Diabetologia | Q5270140 |
P1476 | title | Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis | |
P478 | volume | 50 |
Q37422600 | C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction |
Q26777077 | Cardiovascular disease and type 1 diabetes: prevalence, prediction and management in an ageing population |
Q26828872 | Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases |
Q63488623 | Diabetic fatty liver disease is associated with specific changes in blood-borne markers |
Q36253868 | Direct Observation of Enhanced Nitric Oxide in a Murine Model of Diabetic Nephropathy. |
Q46165413 | Effect of anticoagulants on the plasma hyaluronidase activities. |
Q34283956 | Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus |
Q89030137 | Endothelial Glycocalyx as a Shield Against Diabetic Vascular Complications: Involvement of Hyaluronan and Hyaluronidases |
Q35696044 | Endothelial barrier dysfunction in diabetic conduit arteries: a novel method to quantify filtration |
Q50058490 | Endothelial nanomechanics in the context of endothelial (dys)function and inflammation |
Q33775709 | Endothelial surface layer degradation by chronic hyaluronidase infusion induces proteinuria in apolipoprotein E-deficient mice |
Q24644869 | Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers |
Q33400488 | Glomerular endothelium: a porous sieve and formidable barrier. |
Q34636380 | Hyaluronan as an immune regulator in human diseases. |
Q35660196 | Hyaluronan regulation of vascular integrity |
Q26799151 | Hyaluronan: A Mediator of Islet Dysfunction and Destruction in Diabetes? |
Q48159837 | Hyperglycaemia and aberrated insulin signalling stimulate tumour progression via induction of the extracellular matrix component hyaluronan |
Q26786057 | Hyperglycemia-Induced Changes in Hyaluronan Contribute to Impaired Skin Wound Healing in Diabetes: Review and Perspective |
Q36075964 | Impact of enzymatic degradation of the endothelial glycocalyx on vascular permeability in an awake hamster model. |
Q33857901 | Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation |
Q38209920 | Modulation of endothelial glycocalyx structure under inflammatory conditions. |
Q34074465 | NADPH oxidases regulate CD44 and hyaluronic acid expression in thrombin-treated vascular smooth muscle cells and in atherosclerosis. |
Q92792357 | Noninvasive sublingual microvascular imaging reveals sex-specific reduction in glycocalyx barrier properties in patients with coronary artery disease |
Q54444900 | Peroxisome proliferator-activated receptor γ agonists attenuate hyperglycaemia-induced hyaluronan secretion in vascular smooth muscle cells by inhibiting PKCβ2. |
Q99561828 | Retinal Physiology and Circulation: Effect of Diabetes |
Q37517028 | Serum levels of endothelial glycocalyx constituents in women at 20 weeks' gestation who later develop gestational diabetes mellitus compared to matched controls: a pilot study. |
Q24301715 | Shear stress increases endothelial hyaluronan synthase 2 and hyaluronan synthesis especially in regard to an atheroprotective flow profile |
Q64115102 | Sublingual endothelial glycocalyx and atherosclerosis. A cross-sectional study |
Search more.